These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9878126)

  • 1. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice.
    Arai Y; Takanashi H; Kitagawa H; Okayasu I
    Cytokine; 1998 Nov; 10(11):890-6. PubMed ID: 9878126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
    Kwon KH; Murakami A; Hayashi R; Ohigashi H
    Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH; Murakami A; Tanaka T; Ohigashi H
    Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis.
    Benavides U; Gonzalez-Murguiondo M; Harii N; Lewis CJ; Sakhalkar HS; Deosarkar SP; Kurjiaka DT; Dagia NM; Goetz DJ; Kohn LD
    Eur J Pharmacol; 2010 Sep; 643(1):129-38. PubMed ID: 20550948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
    Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
    Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium.
    Xu L; Yang ZL; Li P; Zhou YQ
    Phytomedicine; 2009 Oct; 16(10):989-95. PubMed ID: 19386481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.
    Martinez JA; Williams CS; Amann JM; Ellis TC; Moreno-Miralles I; Washington MK; Gregoli P; Hiebert SW
    Gastroenterology; 2006 Aug; 131(2):579-88. PubMed ID: 16890610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.
    Ogawa A; Andoh A; Araki Y; Bamba T; Fujiyama Y
    Clin Immunol; 2004 Jan; 110(1):55-62. PubMed ID: 14962796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of dextran sulfate sodium-induced ulcerative colitis model in mice.
    Wang QY; Chen CL; Wang JD; Lai ZS; Liu R; Zhang YL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):608-10. PubMed ID: 12376288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
    Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
    J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.
    Villegas I; Alarcón de la Lastra C; Orjales A; La Casa C
    Int Immunopharmacol; 2003 Dec; 3(13-14):1731-41. PubMed ID: 14636824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
    Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
    Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis.
    Hardin JA; Wallace LE; Wong JF; O'Loughlin EV; Urbanski SJ; Gall DG; MacNaughton WK; Beck PL
    Cell Tissue Res; 2004 Nov; 318(2):313-23. PubMed ID: 15338270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
    Arafa HM; Hemeida RA; El-Bahrawy AI; Hamada FM
    Food Chem Toxicol; 2009 Jun; 47(6):1311-7. PubMed ID: 19285535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.